Alexander O Mujica

This inventor holds 33 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 17 EPO patents, primarily in Genetically Modified Animals. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander O Mujica. Retrieved from https://idiyas.com/inventor/alexander-o-mujica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 14)

% Patents Active = 93.9

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 17 (Patent Applications = 21)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 65(Granted Patents)

Company Filing History:

30 out of 1,479

Regeneron Pharmaceuticals, Inc.

patents

3 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Humanized ASGR1 Locus

Programmed Cell Death 1 Gene

DITRA Disease Model

Humanized Dipeptidyl-Peptidase IV

Cluster of Differentiation 47

Lymphocyte-Activation Gene 3

Targeted Genome Modification

C9ORF72 Locus

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680107 - NON-HUMAN ANIMALS COMPRISING A HUMANIZED ASGR1 LOCUS (2026-07-14),

2. 12677813 - GENETICALLY MODIFIED MICE HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE (2026-07-14),

3. 12471579 - MOUSE MODEL OF DITRA DISEASE AND USES THEREOF (2025-11-18),

4. 12396444 - Mouse comprising a humanized TRKB locus (2025-08-26),

5. 12389889 - Mouse having a humanized cluster of differentiation 47 gene (2025-08-19),

6. 12256720 - Humanized dipeptidyl-peptidase IV (DPP4) animals (2025-03-25),

7. 12096754 - Non-human animals having a humanized lymphocyte-activation gene 3 (2024-09-24),

8. 12037596 - Targeted modification of rat genome (2024-07-16),

9. 11910788 - Mouse having a humanized cluster of differentiation 47 gene (2024-02-27),

10. 11910787 - Rodents having a humanized TMPRSS gene (2024-02-27),

11. 11696572 - Non-human animals comprising a humanized ASGR1 locus (2023-07-11),

12. 11684050 - Non-human animals having a humanized programmed cell death 1 gene (2023-06-27),

13. 11589562 - Mouse model of DITRA disease and uses thereof (2023-02-28),

14. 11419318 - [object Object] (2022-08-23),

15. 11178860 - Humanized C5 animals (2021-11-23),

Title: The Innovative Journey of Alexander O Mujica

Introduction: Alexander O Mujica, a talented inventor hailing from Elmsford, NY, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Mujica's latest patents showcase his prowess in the field of innovation, with a focus on cutting-edge technologies such as artificial intelligence, renewable energy, and biotechnology.

Career Highlights: Throughout his illustrious career, Mujica has been recognized for his innovative spirit and dedication to pushing the boundaries of what is possible. His work has not only earned him numerous patents but has also garnered acclaim from his peers in the industry.

Collaborations: Mujica has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Alexander O Mujica's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations to think outside the box and create a better tomorrow through technology.

Profile summary based on public USPTO records.